If you, as a pharmaceutical company, identify supply shortages of certain medicinal products for human use, you are obliged to report them.

Proposals for the further development of the ICD-10-GM and OPS classifications can be submitted to the Federal Institute for Drugs and Medical Devices from the beginning of December to the end of February as part of the proposal procedure and can then be viewed.

You can view summaries of risk management plans on the portal for drug information of the federal and state governments as a supplement to specialist and package leaflets.